What is Reprieve Cardiovascular worth?
$100.0Mlast known valuation
Reprieve Cardiovascular last raised $30.9M in its Early Stage VC (May 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Reprieve Cardiovascular
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Early Stage VC | $30.9M | ▮ | ▮ |
| Sep 2024 | Debt | $9.5M | ▮ | ▮ |
| Nov 2023 | Early Stage VC | $12.1M | ▮ | ▮ |
| Apr 2022 | Early Stage VC | $15.0M | ▮ | ▮ |
| Jul 2020 | Early Stage VC | $15.0M | ▮ | ▮ |
How Reprieve Cardiovascular's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Reprieve Cardiovascular, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Reprieve Cardiovascular worth?
- Reprieve Cardiovascular's last known valuation is $100.0M.
- How much has Reprieve Cardiovascular raised?
- Reprieve Cardiovascular has raised $103.0M in total funding across 5 recorded rounds.
- When did Reprieve Cardiovascular last raise?
- Reprieve Cardiovascular last raised in May 2025 (Early Stage VC), raising $30.9M.